KSOM faculty named to Highly Cited 2020 list of world’s most influential researchers
Multiple KSOM faculty members were named to the list compiled by Clarivate Analytics.
USC ATRI to participate in landmark study of biomarkers of Alzheimer’s disease in adults with down syndrome
(Photo/iStock) The Alzheimer's Therapeutic Research Institute, Keck School of Medicine of USC (ATRI) will be participating in the Alzheimer’s Biomarker Consortium — Down syndrome (ABC-DS) project. ... Read More »
Meet the doc who worked with the ‘This Is Us’ writers on depiction of Alzheimer’s
Rebecca (Mandy Moore) and Jack (Milo Ventimiglia) on "This Is Us." (Photo/NBC/Instagram) What will become of Rebecca? That's one of the questions fans of the hit ... Read More »
ATRI leads program accelerating recruitment into Alzheimer’s disease clinical trials
Paul Aisen A study team led by Paul Aisen, MD, director of USC’s Alzheimer’s Therapeutic Research Institute, recently published a set of papers describing a program ... Read More »
Paul Aisen interviewed in new release of ‘Turning Point’ documentary
The documentary film “Turning Point” shines a light on the research conducted on Alzheimer’s disease, including at the Keck School of Medicine of USC. The feature-length film, originally released ... Read More »
ATRI Launches Latest Science and Path Forward Program
USC’s Alzheimer’s Therapeutic Research Institute (ATRI) in San Diego launched a new event series to educate the local San Diego community about the vital research being conducted to ... Read More »
Training and diversifying the next generation of Alzheimer’s researchers
The IMPACT-AD program will aim to make the clinical trials’ workforce as diverse and representative as its participants. (Illustration/iStock) USC Alzheimer’s disease researchers have joined ... Read More »
ATRI’s Commitment to Equality, Inclusiveness, and Diversity
Dear ATRI Community, The recent tragedies of George Floyd, Ahmaud Arbery and Breonna Taylor demand that we all address the injustice in our society. These terrible events have ... Read More »
ATRI’s Dr. Paul Aisen to co-lead $75.8 million clinical study for new Alzheimer’s drug
Paul Aisen, MD, director of the Alzheimer’s Therapeutic Research Institute (ATRI) of the Keck School of Medicine at USC, will oversee a study of a new drug in ... Read More »